BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25828248)

  • 1. 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
    Polizzotto MN; Millo C; Uldrick TS; Aleman K; Whatley M; Wyvill KM; O'Mahony D; Marshall V; Whitby D; Maass-Moreno R; Steinberg SM; Little RF; Yarchoan R
    J Infect Dis; 2015 Oct; 212(8):1250-60. PubMed ID: 25828248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
    Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
    Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.
    Bertagna F; Biasiotto G; Rodella R; Giubbini R; Alavi A
    Jpn J Radiol; 2010 Apr; 28(3):231-4. PubMed ID: 20437136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Venkataraman G; Uldrick TS; Aleman K; O'Mahony D; Karcher DS; Steinberg SM; Raffeld MA; Marshall V; Whitby D; Little RF; Yarchoan R; Pittaluga S; Maric I
    Am J Clin Pathol; 2013 May; 139(5):651-61. PubMed ID: 23596117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
    Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
    Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).
    Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Marshall V; Wang V; Whitby D; Pittaluga S; Jaffe ES; Millo C; Tosato G; Little RF; Steinberg SM; Sereti I; Yarchoan R
    Clin Infect Dis; 2016 Mar; 62(6):730-738. PubMed ID: 26658701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.
    Jiang Y; Hou G; Zhu Z; Huo L; Li F; Cheng W
    Nucl Med Commun; 2021 Jul; 42(7):833-838. PubMed ID: 33741858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
    Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.
    Lin IF; Lin JN; Tsai TH; Hsu CT; Wu YY; Lai CH
    Int J STD AIDS; 2021 Mar; 32(3):286-289. PubMed ID: 33555231
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jain L; Mackenzie S; Bomanji JB; Shortman R; Noursadeghi M; Edwards SG; Miller RF
    Int J STD AIDS; 2018 Jun; 29(7):691-694. PubMed ID: 29198183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.
    Kim B; Jeon YK; Kim CW
    J Korean Med Sci; 2009 Oct; 24(5):970-4. PubMed ID: 19795003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
    Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
    Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
    Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi sarcoma herpesvirus-associated cancers and related diseases.
    Goncalves PH; Ziegelbauer J; Uldrick TS; Yarchoan R
    Curr Opin HIV AIDS; 2017 Jan; 12(1):47-56. PubMed ID: 27662501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
    Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
    J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
    Wen KW; Damania B
    Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Fatal Case of Kaposi Sarcoma Immune Reconstitution Syndrome (KS-IRIS) Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) or Multicentric Castleman Disease (MCD): A Case Report and Review.
    Dumic I; Radovanovic M; Igandan O; Savic I; Nordstrom CW; Jevtic D; Subramanian A; Ramanan P
    Am J Case Rep; 2020 Dec; 21():e926433. PubMed ID: 33268763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Polizzotto MN; Uldrick TS; Wang V; Aleman K; Wyvill KM; Marshall V; Pittaluga S; O'Mahony D; Whitby D; Tosato G; Steinberg SM; Little RF; Yarchoan R
    Blood; 2013 Dec; 122(26):4189-98. PubMed ID: 24174627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.
    Corbellino M; Bestetti G; Scalamogna C; Calattini S; Galazzi M; Meroni L; Manganaro D; Fasan M; Moroni M; Galli M; Parravicini C
    Blood; 2001 Dec; 98(12):3473-5. PubMed ID: 11719390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi sarcoma herpesvirus/human herpesvirus 8-positive diffuse large B-cell lymphoma characterized by malignant ascites: A case report.
    Chang LC; Fu PA; Wang SH; Chang KC; Hsu YT
    Pathol Res Pract; 2024 Mar; 255():155185. PubMed ID: 38342036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.